Home > Insider Trading > Filing (0001477449-25-000020)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1477449	Teladoc Health Inc.	TDOC	Services-Offices & Clinics Of Doctors Of Medicine (8011)	043705970

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1780955	Mala Murthy	C/O Teladoc Health, Inc., 2 Manhattanville Road, Suite 203 Purchase NY 10577	Chief Financial Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2025-02-28	3,369	$0.00	96,157	No	4	M	Direct
Common Stock	Acquisiton	2025-02-28	2,044	$0.00	98,201	No	4	M	Direct
Common Stock	Acquisiton	2025-02-28	7,750	$0.00	105,951	No	4	M	Direct
Common Stock	Acquisiton	2025-02-28	2,641	$0.00	108,592	No	4	M	Direct
Common Stock	Disposition	2025-03-03	8,630	$9.68	99,962	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Restricted Stock Units	Disposition	2025-02-28	3,369	$0.00	3,369	$0.00
Common Stock	Restricted Stock Units	Disposition	2025-02-28	2,044	$0.00	2,044	$0.00
Common Stock	Restricted Stock Units	Disposition	2025-02-28	7,750	$0.00	7,750	$0.00
Common Stock	Performance Stock Units	Disposition	2025-02-28	2,641	$0.00	2,641	$0.00
Common Stock	Restricted Stock Units	Acquisiton	2025-03-01	172,594	$0.00	172,594	$0.00

Remaning Holdings	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0	No	4	M	Direct
2,044	No	4	M	Direct
31,004	No	4	M	Direct
10,567	No	4	M	Direct
172,594	No	4	A	Direct

Footnotes

Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
Performance stock units convert to shares of TDOC common stock on a one-for-one basis.
Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance stock unit and restricted stock unit awards.
On March 1, 2022, the reporting person was granted 40,426 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.
On June 1, 2022, the reporting person was granted 24,525 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.
On March 3, 2023, the reporting person was granted 93,006 restricted stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.
On March 1, 2024, the reporting person earned 31,696 performance stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.
Each restricted stock unit represents a contingent right to receive one share of TDOC common stock.
One-third of the restricted stock units vest on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.